Heading
Intro
Throne
Stem Cell Educator (Copy)
Stem Cell Educator Therapy
Stem Cell Educator
Type 1 Diabetes
Alopecia
COVID-19
Additional diseases
Journal Publications
Unrivaled Advantage
Timeline
News
Home
Overview
Diabetes
Alopecia Areata
Expanded Access
Research
Progress
Media
Team

Throne Biotechnologies

Heading
Intro
Throne
Stem Cell Educator (Copy)
Stem Cell Educator Therapy
Stem Cell Educator
Type 1 Diabetes
Alopecia
COVID-19
Additional diseases
Journal Publications
Unrivaled Advantage
Timeline
News
Home
Overview
Diabetes
Alopecia Areata
Expanded Access
Research
Progress
Media
Team
September 19, 2017
Throne Biotechnologies

Press release: the children T1D trial has demonstrated the clinical safety and efficacy of Stem Cell Educator therapy for the treatment of children with type 1 diabetes.

September 19, 2017
Throne Biotechnologies

Press release from the Second Xiangya Hospital of Central South University: the children T1D trial (NCT01996228) has demonstrated the clinical safety and efficacy of Stem Cell Educator therapy for the treatment of children with type 1 diabetes (n = 40). This project has been supported by the Ministry of Science and Technology of the P.R. China.   

September 19, 2017
Throne Biotechnologies

Throne Biotechnologies

Beijing 301 Military Hospital opens up a new clinical trial of Stem Cell Educator therapy for the treatment of insulin resistance in type 2 diabetes
Dr.Zhao and his team reveal new mechanisms underlying Stem Cell Educator therapy and open up new avenues to improve the treatment of diabetes in clinics.

Paramus, New Jersey - New York City Metro

connect@thronebio.com

Back To Top
 

Life is in

Throne logo mark - full color.png
 

the Blood

© 2025 Throne Biotechnologies Inc., All rights reserved.